| Dr Jonathan Andrew Hoda, MD | |
|
5651 Frist Blvd Ste 603, Hermitage, TN 37076-2079 | |
| (615) 889-1968 | |
| (615) 889-8527 |
| Full Name | Dr Jonathan Andrew Hoda |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 17 Years |
| Location | 5651 Frist Blvd Ste 603, Hermitage, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053519785 | NPI | - | NPPES |
| 301042 | Medicaid | SC | |
| P01356934 | Other | MS | RAILROAD MEDICARE |
| 07280861 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | LL30104 (South Carolina) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 53648 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Summit Medical Center | Hermitage, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centennial Heart Llc | 9931204237 | 115 |
News Archive
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
An international team of researchers have developed a new method for measurement of aggregated beta-amyloid - a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer's disease. The new method might facilitate diagnosis and detection as well as development of drugs directed against aggregated beta-amyloid.
Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that on September 29, 2011, it has purchased an additional 5,443,771 shares of Axis-Shield stock, bringing its total current ownership position to 10,990,468 shares, or approximately 21.98%, of Axis-Shield's issued and outstanding ordinary share capital.
The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and constantly evolving mobile ecosystem. Specifically, the GSMA will shine a spotlight on innovation in the mobile health – 'mHealth' – space for the first time.
› Verified 6 days ago
| Entity Name | Centennial Heart Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245393057 PECOS PAC ID: 9931204237 Enrollment ID: O20070416000188 |
News Archive
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
An international team of researchers have developed a new method for measurement of aggregated beta-amyloid - a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer's disease. The new method might facilitate diagnosis and detection as well as development of drugs directed against aggregated beta-amyloid.
Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that on September 29, 2011, it has purchased an additional 5,443,771 shares of Axis-Shield stock, bringing its total current ownership position to 10,990,468 shares, or approximately 21.98%, of Axis-Shield's issued and outstanding ordinary share capital.
The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and constantly evolving mobile ecosystem. Specifically, the GSMA will shine a spotlight on innovation in the mobile health – 'mHealth' – space for the first time.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Andrew Hoda, MD 5651 Frist Blvd Ste 603, Hermitage, TN 37076-2079 Ph: (615) 889-1968 | Dr Jonathan Andrew Hoda, MD 5651 Frist Blvd Ste 603, Hermitage, TN 37076-2079 Ph: (615) 889-1968 |
News Archive
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
An international team of researchers have developed a new method for measurement of aggregated beta-amyloid - a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer's disease. The new method might facilitate diagnosis and detection as well as development of drugs directed against aggregated beta-amyloid.
Northeastern University professor Mark C. Williams and colleague Ioana Vladescu have discovered a novel method for studying the DNA binding of small molecules with unprecedented accuracy.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that on September 29, 2011, it has purchased an additional 5,443,771 shares of Axis-Shield stock, bringing its total current ownership position to 10,990,468 shares, or approximately 21.98%, of Axis-Shield's issued and outstanding ordinary share capital.
The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and constantly evolving mobile ecosystem. Specifically, the GSMA will shine a spotlight on innovation in the mobile health – 'mHealth' – space for the first time.
› Verified 6 days ago
Mr. Michael Thomas Beckham, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5651 Frist Blvd Ste 701, Hermitage, TN 37076 Phone: 615-964-7990 Fax: 615-649-8079 | |
Dr. Frank Christopher Adamini, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5655 Frist Blvd, Hermitage, TN 37076 Phone: 615-316-3000 | |
Dr. Chirag Jitendra Amin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5653 Frist Blvd, Suite 434, Hermitage, TN 37076 Phone: 615-871-9996 Fax: 615-871-9661 | |
Gurbans Singh Deol, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5655 Frist Blvd, Hermitage, TN 37076 Phone: 615-316-3000 | |
Dr. Deborah G Montgomery, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5653 Frist Blvd, Suite 630, Hermitage, TN 37076 Phone: 615-391-3971 Fax: 615-345-0942 | |
James V Tedesco, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5653 Frist Blvd, Suite 630, Hermitage, TN 37076 Phone: 615-391-3971 Fax: 615-369-2032 |